Drug
Keratolytic Antifungal
Keratolytic Antifungal: highest development phase Not Applicable, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Not Applicable
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| Keratolytic/Antifungal NCT00808366 | Not Applicable | Onychomycosis |
Latest
No recent events.
Follow Keratolytic Antifungal on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.